In a report released today, Derek Archila from Stifel Nicolaus reiterated a Buy rating on NGM Biopharmaceuticals (NGM), with a price target of ...
The post NGM Biopharmaceuticals (NGM) Receives a Buy from Stifel Nicolaus appeared first on Smarter Analyst.
In a report released today, Derek Archila ...

https://www.smarteranalyst.com/new-blurbs/ngm-biopharmaceuticals-ngm-receives-a-buy-from-stifel-nicolaus/

#SmarterAnalyst